Сингапур - английский - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - pathology - ventana pd-l1 (sp263) assay is intended for the qualitative detection of the programmed death ligand 1 (pd-l1) protein in formalin-fixed, paraffin-embedded (ffpe) non-small cell lung cancer (nsclc) tissue stained with optiview dab ihc detection kit on a benchmark ihc/ish instrument. pd-l1 expression in tumor cell (tc) membrane as detected by ventana pd-l1 (sp263) assay in nsclc is indicated as an aid in identifying patients for treatment with imfinzi™ (durvalumab), keytruda® (pembrolizumab) and tecentriq® (atezolizumab). pd-l1 expression in tumor cell (tc) membrane as detected by ventana pd-l1 (sp263) assay in nsclc may be associated with enhanced survival from opdivo® (nivolumab).

Малайзия - английский - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sdn. bhd. - avelumab -

Сингапур - английский - HSA (Health Sciences Authority)

pierre fabre singapore pte. ltd. - encorafenib - capsule - encorafenib 50mg

Сингапур - английский - HSA (Health Sciences Authority)

pierre fabre singapore pte. ltd. - binimetinib - tablet, film coated - binimetinib 15mg